These findings highlight inhibition of PI3Kγ/AKT/mTOR-mediated CXCR4 signaling as a component of the mechanism by which PTP1B inhibitors protected against lung injury in the TRALI model and improved survival in LPS-induced sepsis model (Figure 6E). The gene discussed is MTOR; the disease is Sepsis.